Currently funded projects
Molecular and clinical characterization of long-term effects in cancer survivors
Institution: Department of Hematology, Oncology and Cancer Immunology
Applicant: PD Dr Mareike Frick
EKFS funding line: Else Kröner Excellence Fellowships
Deciphering and Overcoming Resistance Towards Afatinib in NRG1 Rearranged Cancers
Institution: Department of Medical Oncology, National Center for Tumor Diseases (NCT) Heidelberg, University Hospital Heidelberg
Applicant: Dr Sebastian Dieter
EKFS funding line: Else Kröner Excellence Fellowships
An adjustable MLL-ENL derived transcription factor for in vitro manufacturing and in vivo application of human phagocytes
Institution: LMU Klinikum
Applicants: PD Dr. med. Christian Wichmann and Prof. Dr. med. Philipp Greif
EKFS funding line: Key project
Immunooncology and local interventions (IOLIN)
Institution: Klinikum der Ludwig-Maximilians-Universität München
Applicants: Prof. Dr. Sebastian Kobold (Speaker), Prof. Dr. Kirsten Lauber (deputy speaker), Prof. Dr. Dr. Michael von Bergwelt (deputy speaker)
EKFS funding line: Else Kröner Research School
Innovative strategies for optimization of randomized therapeutic trials using molecular imaging and artificial intelligence
Institution: Clinic for Nuclear Medicine and Münster University Hospital, Clinic for Nuclear Medicine, University Hospital Essen
Applicant: Dr. Robert Seifert
EKFS funding line: Else Kröner Memorial Fellowships
Identification of novel targets for personalized treatment in metastatic uveal melanoma
Institution: Department of Dermatology, Universitätsklinikum Erlangen
Applicant: Markus Heppt
EKFS funding line: Else Kröner Excellence Fellowships
Click chemistry and cyclotherapy in tumor therapy
Institution: 2. Med. Klinik, Klinikum rechts der Isar, Technische Universität München
Applicant: Dr. med. Dr. rer. nat. Yizhu Li
EKFS funding line: First and Second Applications
Improving efficacy of checkpoint blockade therapy for hepatocellular carcinoma with in situ vaccination
Institution: Department of Hepatology and Gastroenterology, Charité Universitaetsmedizin Berlin
Applicant: Dr. rer. nat. Linda Hammerich
EKFS funding line: First and Second Applications
Molecular Mechanisms of Tumor Cell Interactions in Follicular Lymphoma (MOMENTUM-FL)
Institution: Hospital of the Ludwig-Maximilians-University (LMU), Munich. Medical Department III
Applicant: Prof. Dr. Oliver Weigert
EKFS funding line: Else Kröner Excellence Fellowship
MR-spectroscopic in vivo metabolic profiling – a novel „omic“ in the multi-omics assessment of diffuse large B-cell lymphoma
Institution: Department of Neuroradiology, University Hospital Frankfurt, Goethe University, Mildred Scheel Career Center Frankfurt
Applicant: PD Dr. Katharina Wenger-Alakmeh
EKFS funding line: First and Second Applications